top of page
Latest News
Gene Therapy – An American Innovation Worth Fighting For
Authors: IGT Chairman Erik Paulsen, Scientific Academic and Medical Council Chair Donna Christian-Christensen, M.D. As our nation’s...
5 days ago
Reflecting on Five Years of IGT: Our Commitment to Patients and Innovation
As we commemorate the fifth anniversary of the Institute for Gene Therapies (IGT) today, I want to take a look back at the strides we've...
Feb 14
ICYMI: IGT Chair Erik Paulsen and Scientific, Academic and Medical Council Chair Donna M. Christensen on the Future of Gene Therapy
IGT leaders recently penned a piece exploring the strides being made in gene therapy and highlighting the ongoing challenges that must be...
Dec 3, 2024
The Federal Newborn Screening Program at a Crossroads
As Newborn Screening Awareness Month concludes, IGT applauds the tireless work of advocates who dedicate themselves 365 days of the year...
Oct 3, 2024
What Newborn Screening Really Means in the Sickle Cell Disease Community and Beyond
Author: Andrea Matthews, Founder, Children’s Sickle Cell Foundation, Inc.  Newborn screening (NBS) is an important public health measure...
Sep 24, 2024
IGT Patient Advocacy Advisory Council Members Recognize Newborn Screening Awareness Month
Newborn screening is critical to ensure faster access to treatment and cures for genetic conditions. This September, IGT is recognizing...
Aug 30, 2024
bottom of page